Nutraceutical International Corporation reported unaudited consolidated earnings results for the second quarter and six months ended March 31, 2016. For the second quarter, the company's net sales for the fiscal 2016 second quarter were $59.49 million compared to $55.4 million for the same quarter of fiscal 2015. For the second quarter of fiscal 2016, net income was $4.62 million, or $0.49 diluted earnings per share, compared to net income of $4.1 million, or $0.43 diluted earnings per share, for the same quarter of fiscal 2015. Income from operations was $7.551 million against $6.738 million a year ago. Income before provision for income taxes was $7.229 million against $6.465 million a year ago. Adjusted EBITDA was $11.089 million against $10.006 million a year ago.

For the six months, the company's net sales for the six months ended March 31, 2016 were $115.451 million compared to $108.4 million for the same period of fiscal 2015. For the six months ended March 31, 2016, net income was $8.859 million, or $0.94 diluted earnings per share, compared to net income of $7.4 million, or $0.77 diluted earnings per share, for the same period of fiscal 2015. Operating cash flow for the six months ended March 31, 2016 was $17.3 million, compared to $11.2 million for the same period of fiscal 2015.  The operating cash flow for the six months ended March 31, 2016, combined with net borrowings of $16.0 million, was primarily used to invest $26.2 million in acquisitions of natural product businesses, $4.0 million in purchases of property, plant and equipment and $3.6 million in purchases of common stock for treasury. Income from operations was $14.336 million against $12.307 million a year ago. Adjusted EBITDA was $21.356 million against $18.814 million a year ago.